21-44908184-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000211.5(ITGB2):c.148-1089A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.847 in 719,108 control chromosomes in the GnomAD database, including 259,384 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.87 ( 58166 hom., cov: 31)
Exomes 𝑓: 0.84 ( 201218 hom. )
Consequence
ITGB2
NM_000211.5 intron
NM_000211.5 intron
Scores
7
Splicing: ADA: 0.00002529
2
Clinical Significance
Conservation
PhyloP100: -3.48
Genes affected
ITGB2 (HGNC:6155): (integrin subunit beta 2) This gene encodes an integrin beta chain, which combines with multiple different alpha chains to form different integrin heterodimers. Integrins are integral cell-surface proteins that participate in cell adhesion as well as cell-surface mediated signalling. The encoded protein plays an important role in immune response and defects in this gene cause leukocyte adhesion deficiency. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_addAF=-0.906843).
BP6
Variant 21-44908184-T-C is Benign according to our data. Variant chr21-44908184-T-C is described in ClinVar as [Benign]. Clinvar id is 803634.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr21-44908184-T-C is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.959 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ITGB2 | NM_000211.5 | c.148-1089A>G | intron_variant | ENST00000652462.1 | NP_000202.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ITGB2 | ENST00000652462.1 | c.148-1089A>G | intron_variant | NM_000211.5 | ENSP00000498780.1 |
Frequencies
GnomAD3 genomes AF: 0.872 AC: 132527AN: 152022Hom.: 58100 Cov.: 31
GnomAD3 genomes
AF:
AC:
132527
AN:
152022
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.851 AC: 157890AN: 185526Hom.: 67506 AF XY: 0.850 AC XY: 87151AN XY: 102482
GnomAD3 exomes
AF:
AC:
157890
AN:
185526
Hom.:
AF XY:
AC XY:
87151
AN XY:
102482
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.841 AC: 476683AN: 566968Hom.: 201218 Cov.: 0 AF XY: 0.844 AC XY: 258338AN XY: 306226
GnomAD4 exome
AF:
AC:
476683
AN:
566968
Hom.:
Cov.:
0
AF XY:
AC XY:
258338
AN XY:
306226
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.872 AC: 132651AN: 152140Hom.: 58166 Cov.: 31 AF XY: 0.872 AC XY: 64848AN XY: 74360
GnomAD4 genome
AF:
AC:
132651
AN:
152140
Hom.:
Cov.:
31
AF XY:
AC XY:
64848
AN XY:
74360
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
3038
ALSPAC
AF:
AC:
3156
ESP6500AA
AF:
AC:
1666
ESP6500EA
AF:
AC:
3260
ExAC
AF:
AC:
91552
Asia WGS
AF:
AC:
3058
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan | Jan 24, 2024 | This variant is classified as Benign based on local population frequency. This variant was detected in 99% of patients studied by a panel of primary immunodeficiencies. Number of patients: 94. Only high quality variants are reported. - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Leukocyte adhesion deficiency 1 Benign:1
Benign, criteria provided, single submitter | clinical testing | Mendelics | May 28, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at